Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion type Assertion NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_head.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion wasGeneratedBy ECO_0000203 NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_provenance.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion wasDerivedFrom befree-2016 NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_provenance.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion SIO_000772 16875940 NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_provenance.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion evidence source_evidence_literature NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_provenance.
- NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_assertion description "[We propose that the del(20q) may have different clinical significance in plasma cell dyscrasia: one is when del(20q) appears at diagnosis and may involve the initial event of oncogenesis, and the other is when del(20q) appears after treatment and is associated with therapy-related and potential MDS/AML risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561893.RAgKoyuVnuMiY4RQMhnMF8LoBmaVmu9O8zj_SrXuljYhA130_provenance.